Skip to main content
Clinical Trials/NCT06614257
NCT06614257
Completed
Not Applicable

REduced Pain After Bariatric Surgery - Gastric Bypass (REPABS-BPG)

Fondazione Policlinico Universitario Campus Bio-Medico1 site in 1 country84 target enrollmentJanuary 4, 2022

Overview

Phase
Not Applicable
Intervention
LG-TAP block with local anesthetic
Conditions
Pain
Sponsor
Fondazione Policlinico Universitario Campus Bio-Medico
Enrollment
84
Locations
1
Primary Endpoint
Pain Score
Status
Completed
Last Updated
last year

Overview

Brief Summary

This study aims to analyze the effect of laparoscopic guided transversus abdominis plane (LG-TAP) block compared to placebo for postoperative analgesia following laparoscopic gastric bypass. One group of participants received a (LG-TAP) block with local anesthetic while the other group received (LG-TAP) block with saline solution (placebo).

Registry
clinicaltrials.gov
Start Date
January 4, 2022
End Date
March 8, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Vincenzo Bruni

Principal Investigator

Fondazione Policlinico Universitario Campus Bio-Medico

Eligibility Criteria

Inclusion Criteria

  • Elective Laparoscopic Gastric Bypass
  • Body Mass Index (BMI) \> 35 kg/m² and at least one condition related to obesity (e.g., hypertension, type II diabetes, dyslipidemia, hepatic steatosis, etc)
  • BMI \> 40 kg/m², even in the absence of comorbidities
  • ASA physical status score \< 4

Exclusion Criteria

  • ASA physical status score ≥ 4
  • Patient's refusal or inability to sign the informed consent
  • Allergies to any drug provided by the study protocol

Arms & Interventions

LG-TAP

The laparoscopic guided TAP Block was performed at the beginning of surgery, injecting 15 ml of Local Anesthetic (Ropivacaine Hydrochloride 0.5%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.

Intervention: LG-TAP block with local anesthetic

LG-TAP

The laparoscopic guided TAP Block was performed at the beginning of surgery, injecting 15 ml of Local Anesthetic (Ropivacaine Hydrochloride 0.5%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.

Intervention: Port site infiltration

PLACEBO

The laparoscopic guided TAP Block was performed at the beginning of surgery, injecting 15 ml of Saline solution (NaCl 0.9%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.

Intervention: Port site infiltration

PLACEBO

The laparoscopic guided TAP Block was performed at the beginning of surgery, injecting 15 ml of Saline solution (NaCl 0.9%) on each side, using an atraumatic needle (10/15 cm length, 20 Gauge diameter) close to the anterior axillary line, between the iliac crest and the subcostal margin. Correct needle tip positioning between the transverse muscle of the abdomen and the internal oblique was verified through laparoscopic guidance.

Intervention: LG-TAP block with saline solution

Outcomes

Primary Outcomes

Pain Score

Time Frame: 24 hours

A numerical rating scale (NRS) from 0 (no pain) to 10 (worst imaginable pain) will be used to evaluate pain at rest during 24 hours after surgery

Secondary Outcomes

  • Morphine Consumption(24 hours)
  • Ketorolac Consumption(24 hours)
  • Nausea and/or Vomiting(48 hours)
  • Length of Hospital Stay(72 hours)
  • Timt to walking(72 hours)
  • Time to first flatus(72 hours)
  • Surgical Complications(7 days)

Study Sites (1)

Loading locations...

Similar Trials